Japanese Encephalitis Vaccine — Who Needs It for Asia Travel?

Japanese Encephalitis comes up regularly in travel vaccine consultations for Asia, but there's a lot of confusion about who actually needs it. It's sometimes over-recommended for short beach holidays and sometimes missed for people who genuinely should have it.

What Japanese Encephalitis is

JE is a viral infection spread by Culex mosquitoes, which breed in irrigated rice fields and slow-moving water. Most infections are asymptomatic or mild, but a small proportion progress to encephalitis — inflammation of the brain — with a case fatality rate of 20–30% in severe cases, and neurological damage in around half of survivors. There is no specific treatment. The vaccine is highly effective.

Who the risk applies to

The risk of JE is strongly linked to rural exposure, proximity to rice cultivation, and duration of travel. Short trips to major Asian cities — Bangkok, Tokyo, Kuala Lumpur, Bali resort areas — carry very low risk. The risk increases for travellers spending extended time in rural areas, particularly during and after monsoon season when mosquito populations peak.

High-risk scenarios include extended rural travel in Thailand, Vietnam, India, China, Indonesia, or the Philippines during summer/monsoon months; volunteer work in agricultural settings; and long-term residence in rural Asia.

Low-risk scenarios where JE is sometimes unnecessary

A two-week beach holiday in Phuket, a city trip to Tokyo, a cruise stopping in Asian ports, or a resort stay in Bali. The vaccine is sometimes recommended in these contexts at travel clinics but the risk-benefit calculation doesn't strongly support it for short urban or coastal trips. If you're unsure, ask your clinic specifically about your itinerary — "I'm spending 10 days in Bangkok and 4 days in Chiang Mai, staying in tourist hotels" is a different risk profile from "I'm cycling rural Vietnam for 6 weeks during monsoon."

The vaccine

Ixiaro is the most widely available JE vaccine in Europe and Australia. It requires two doses, with the second given 28 days after the first — so you need at least 5 weeks of lead time. A booster after 12–24 months is recommended if ongoing exposure. The vaccine is well-tolerated with mostly mild local reactions.